U.S. PHARMACOPEIA

Search USP29  
Azithromycin Capsules
» Azithromycin Capsules contain the equivalent of not less than 90.0 percent and not more than 110.0 percent of the labeled amount of azithromycin (C38H72N2O12).
Packaging and storage— Preserve in well-closed containers. Where packaged in unit-of-use containers, each container contains six 250-mg Capsules, and the label indicates the intended sequential day of use for each Capsule.
Identification— The retention time of the azithromycin peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711 [NOTE—Use water that has a resistivity of not less than 18 Mohm-cm.]
pH 6.0 sodium phosphate buffer— Prepare 6 L of 0.1 M dibasic sodium phosphate, adjust with about 40 mL of hydrochloric acid to a pH of 6.0 ± 0.05, add 600 mg of trypsin, and mix.
Medium: pH 6.0 sodium phosphate buffer; 900 mL.
Apparatus 2: 100 rpm.
Time: 45 minutes.
Standard solution— Transfer about 15 mg of USP Azithromycin RS, accurately weighed, to a 50-mL volumetric flask. Add 25 mL of Medium, and sonicate briefly to dissolve. Dilute with Medium to volume, and mix. Transfer 2.0 mL of this solution to a 25-mL volumetric flask, dilute with Mobile phase (prepared as directed in the Assay) to volume, and mix. Transfer 4.0 mL of this solution to a second 25-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Test solution— Filter a portion of the solution under test through a filter having a porosity of 0.5 µm or less. Transfer 2.0 mL of the filtrate to a 25-mL volumetric flask, dilute with Mobile phase to volume, and mix. Transfer 4.0 mL of this solution to a second 25-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Procedure— Determine the amount of azithromycin (C38H72N2O12) dissolved, using filtered portions of the solution under test, and employing the procedure set forth in the Assay, making any necessary modifications. Calculate the quantity, in mg, of azithromycin (C38H72N2O12) dissolved by the formula:
70.31(CP)(rU / rS),
in which C is the concentration, in mg per mL, of USP Azithromycin RS in the Standard solution; P is the potency, in µg, of azithromycin (C38H72N2O12) per mg of USP Azithromycin RS; and rU and rS are the azithromycin peak responses obtained from the Test solution and the Standard solution, respectively.
Tolerances— Not less than 75% (Q) of the labeled amount of azithromycin (C38H72N2O12) is dissolved in 45 minutes.
Uniformity of dosage units 905 meet the requirements.
Water, Method I 921: not more than 5.0%.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay—
Mobile phase, Standard preparation, Resolution solution, and Chromatographic system— Proceed as directed in the Assay under Azithromycin.
Assay preparation— Remove, as completely as possible, the contents of not fewer than 20 Capsules, and weigh accurately. Mix the combined contents, and transfer an accurately weighed quantity of the powder, equivalent to about 250 mg of anhydrous azithromycin, to a 250-mL volumetric flask. Add about 175 mL of acetonitrile, and shake by mechanical means for 30 minutes. Dilute with acetonitrile to volume, and mix. Place about 40 mL of the resulting suspension in a centrifuge tube, and centrifuge. Transfer 2.0 mL of the clear supernatant to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix. Transfer 2.0 mL of this solution to a 25-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Procedure— Proceed as directed for Procedure in the Assay under Azithromycin. Calculate the quantity, in mg, of azithromycin (C38H72N2O12) in the portion of Capsules taken by the formula:
(312.5CP / 4)(rU / rS),
in which C is the concentration, in mg per mL, of USP Azithromycin RS in the Standard preparation; P is the potency, in µg of azithromycin (C38H72N2O12) per mg, of USP Azithromycin RS; and rU and rS are the azithromycin peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Brian D. Gilbert, Ph.D., Scientist
Expert Committee : (MDANT05) Monograph Development-Antibiotics
USP29–NF24 Page 228
Pharmacopeial Forum : Volume No. 27(6) Page 3394
Phone Number : 1-301-816-8223